Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptide-chain-release factor 3 (RF3) is a GTPase enzyme found in a broad range of bacteria. It plays an essential role in the termination phase of protein synthesis by facilitating the recycling and removal of class I release factors (RF1 and RF2) from the ribosome after peptide release. RF3 also contributes to quality control during translation. It can stimulate premature termination on aberrant peptides, thereby enhancing fidelity by preventing accumulation of faulty proteins.
Not applicable, as it's a target for potential inhibition, not a drug itself. Potential mechanisms involve disrupting GTP binding/hydrolysis or interfering with RF1/RF2 interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptide-chain-release factor 3 (RF3).